The rapid spread of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome–coronavirus 2 (SARS-CoV-2), has resulted in an unprecedented …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into …

COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …

The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …

The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
disease (COVID-19) in China has been brought to global attention and declared a pandemic …

Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently
leads to fatal inflammatory responses and acute lung injury. Here, we discuss the various …

Currently, humans are immersed in a pandemic caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health …

Since December 2019, the world has been experiencing the challenge of facing coronavirus
disease-19 (COVID-19), a severe infectious disease caused by the new coronavirus, SARS …

The Coronavirus Disease 2019 (COVID-19) has already caused hundreds of thousands of
deaths worldwide in a few months. Cardiovascular disease, hypertension, diabetes and …

Objective: Alveolar-capillary endothelial cells can be activated by severe acute respiratory
syndrome coronavirus 2 infection leading to cytokine release. This could trigger endothelial …